Agreed. Venous thromboembolism is increased in RA (>2 fold) and other inflammatory disorders (SLE, APL syndrome, GPA, IBD, Behcets) but is not increased with TNF inhibitors, which appear to offset this increased RA risk. We published a review of this in 2012 in the Drug Safety Quarterly . http://buff.ly/29shss8. Good reminder! JC